These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35648057)

  • 1. Hematological Alterations in Patients Recovered from SARS-CoV-2 Infection in Havana, Cuba.
    Pereira-Roche N; Roblejo-Balbuena H; Marín-Padrón LC; Izaguirre-Rodríguez R; Sotomayor-Lugo F; Zúñiga-Rosales Y; González-Torres MLÁ; Pérez-Rodríguez J; Álvarez-Gavilán Y; Torres-Rives B; Bravo-Ramírez M; Benítez-Codero Y; Monzón-Benítez G; Silva-Ayçaguer LC; Marcheco-Teruel B
    MEDICC Rev; 2022 May; 24(2):7-14. PubMed ID: 35648057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March-June 2020: Epidemiological Implications.
    Cruz-Rodríguez E; Baldoquín-Rodríguez W; Molina-Águila N; Galindo-Santana BM; Romero-Placeres M; González-Gross TM; Morgado-Vega I; Olivera-Nodarse Y; Guadalupe-Guzmán M
    MEDICC Rev; 2022 Jan; 24(1):21-27. PubMed ID: 35157635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.
    Molina-Águila N; Cruz-Rodríguez E; Ferrán-Torres RM; Galindo-Santana BM; López-Almaguer Y; Romero-Placeres M
    MEDICC Rev; 2021 Apr; 23(2):15. PubMed ID: 33974611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Hemodynamic Reserve Abnormalities Detected Via Transcranial Doppler Ultrasound in Recovered COVID-19 Patients.
    Abdo-Cuza AA; Hall-Smith C; Suárez-López J; Castellanos-Gutiérrez R; Blanco-González MÁ; Machado-Martínez R; Pi-Ávila J; Gómez-Peire F; Espinosa-Nodarse N; López-González JC
    MEDICC Rev; 2022 Jan; 24(1):28-31. PubMed ID: 35157636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation.
    Ruan Y; Hu B; Liu Z; Liu K; Jiang H; Li H; Li R; Luan Y; Liu X; Yu G; Xu S; Yuan X; Wang S; Yang W; Ye Z; Liu J; Wang T
    Andrology; 2021 Jan; 9(1):99-106. PubMed ID: 33150723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19.
    Gacci M; Coppi M; Baldi E; Sebastianelli A; Zaccaro C; Morselli S; Pecoraro A; Manera A; Nicoletti R; Liaci A; Bisegna C; Gemma L; Giancane S; Pollini S; Antonelli A; Lagi F; Marchiani S; Dabizzi S; Degl'Innocenti S; Annunziato F; Maggi M; Vignozzi L; Bartoloni A; Rossolini GM; Serni S
    Hum Reprod; 2021 May; 36(6):1520-1529. PubMed ID: 33522572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study.
    Joukar F; Yaghubi Kalurazi T; Khoshsorour M; Taramian S; Mahfoozi L; Balou HA; Jafarinezhad A; Pourkazemi A; Hesni E; Asgharnezhad M; Shenagari M; Jahanzad I; Naghipour M; Maroufizadeh S; Mansour-Ghanaei F
    Virol J; 2021 Jul; 18(1):134. PubMed ID: 34210325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients with Coronavirus Disease 2019.
    Kim DY; Bae EK; Seo JW; Yun NR; Kim CM; Kim DM
    Microbiol Spectr; 2021 Oct; 9(2):e0079321. PubMed ID: 34704783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of SARS-CoV-2 Rapid Antigen Tests in Use on the Isle of Youth, Cuba.
    González-Fiallo S; Mena-Rodríguez I; Castro-Batista P; Doeste-Hernández VM; Louit-Laborit V
    MEDICC Rev; 2022 May; 24(2):15-19. PubMed ID: 35648058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.
    Dao TL; Hoang VT; Gautret P
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):13-25. PubMed ID: 33113040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
    Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
    JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
    Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
    Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.